Market Cap 802.71M
Revenue (ttm) 348.88M
Net Income (ttm) 42.42M
EPS (ttm) N/A
PE Ratio 15.13
Forward PE 21.30
Profit Margin 12.16%
Debt to Equity Ratio 0.01
Volume 1,540,700
Avg Vol 875,408
Day's Range N/A - N/A
Shares Out 148.10M
Stochastic %K 3%
Beta 1.57
Analysts Strong Sell
Price Target $11.80

Company Profile

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techni...

Industry: Biotechnology
Sector: Healthcare
Phone: 770 651 9100
Address:
1775 West Oak Commons Court, NE, Marietta, United States
WarrenDouglasTrader
WarrenDouglasTrader Jan. 19 at 5:32 PM
1 · Reply
Daddys_Home
Daddys_Home Jan. 19 at 4:14 PM
$MDXG Like old MLK, I also had a dream last night..........#doomsdayq1forcastiscoming (MDXG will lose 100-150m in rev in 2026)
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jan. 19 at 4:12 PM
0 · Reply
Daddys_Home
Daddys_Home Jan. 19 at 3:25 PM
$MDXG is the next Blockbuster. You say you will gain market share, but what you fail to see is that at $127/sqcm there is no market in site 11 (Private Office setting; MDXG is on track to lose 100-150m in Celera / Emerge in 2026) #doomsdayq1forcastiscoming #changemymind (please use math)
0 · Reply
Boeetger
Boeetger Jan. 19 at 5:53 AM
$MDXG Confirmed: Private and hospital sales are business as usual, the only thing that has changed is price of $127. Companies that were abusing the system charging thousands per sq cm are closing doors and/or experiencing mass layoffs. Mimedx is gaining market share and will be one of only a few left standing. These prices are a steal.
1 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jan. 19 at 5:19 AM
$MDXG Confirmed: Private and hospital sales are business as usual, the only thing that has changed is price of $127. Companies that were abusing the system charging thousands per sq cm are closing doors and/or experiencing mass layoffs. Mimedx is gaining market share and will be one of only a few left standing. These prices are a steal.
1 · Reply
Mobagri
Mobagri Jan. 19 at 5:14 AM
$MDXG Tuesday will be a blood bath around 10:30 am for this stock. Expect a big drop.
1 · Reply
RUDYRUDY
RUDYRUDY Jan. 18 at 6:03 AM
0 · Reply
Daddys_Home
Daddys_Home Jan. 17 at 6:18 PM
$MDXG Since old Paul Revere issued his first warning to y’all about $MDXG little secret on 01/06/26 the stock has dropped from $6.50 to a new 52 week low of 5.38📉📉📉📉 🤔 Don’t hate the messenger…..get out while you can!!!😰📉⌛️ #doomsdayq1forcastiscoming
0 · Reply
Avocado_smash
Avocado_smash Jan. 17 at 5:12 PM
$MDXG PT 4.82--
1 · Reply
Latest News on MDXG
No data available.
WarrenDouglasTrader
WarrenDouglasTrader Jan. 19 at 5:32 PM
1 · Reply
Daddys_Home
Daddys_Home Jan. 19 at 4:14 PM
$MDXG Like old MLK, I also had a dream last night..........#doomsdayq1forcastiscoming (MDXG will lose 100-150m in rev in 2026)
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jan. 19 at 4:12 PM
0 · Reply
Daddys_Home
Daddys_Home Jan. 19 at 3:25 PM
$MDXG is the next Blockbuster. You say you will gain market share, but what you fail to see is that at $127/sqcm there is no market in site 11 (Private Office setting; MDXG is on track to lose 100-150m in Celera / Emerge in 2026) #doomsdayq1forcastiscoming #changemymind (please use math)
0 · Reply
Boeetger
Boeetger Jan. 19 at 5:53 AM
$MDXG Confirmed: Private and hospital sales are business as usual, the only thing that has changed is price of $127. Companies that were abusing the system charging thousands per sq cm are closing doors and/or experiencing mass layoffs. Mimedx is gaining market share and will be one of only a few left standing. These prices are a steal.
1 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jan. 19 at 5:19 AM
$MDXG Confirmed: Private and hospital sales are business as usual, the only thing that has changed is price of $127. Companies that were abusing the system charging thousands per sq cm are closing doors and/or experiencing mass layoffs. Mimedx is gaining market share and will be one of only a few left standing. These prices are a steal.
1 · Reply
Mobagri
Mobagri Jan. 19 at 5:14 AM
$MDXG Tuesday will be a blood bath around 10:30 am for this stock. Expect a big drop.
1 · Reply
RUDYRUDY
RUDYRUDY Jan. 18 at 6:03 AM
0 · Reply
Daddys_Home
Daddys_Home Jan. 17 at 6:18 PM
$MDXG Since old Paul Revere issued his first warning to y’all about $MDXG little secret on 01/06/26 the stock has dropped from $6.50 to a new 52 week low of 5.38📉📉📉📉 🤔 Don’t hate the messenger…..get out while you can!!!😰📉⌛️ #doomsdayq1forcastiscoming
0 · Reply
Avocado_smash
Avocado_smash Jan. 17 at 5:12 PM
$MDXG PT 4.82--
1 · Reply
SnapCrackleStop
SnapCrackleStop Jan. 17 at 4:28 PM
$MDXG Still waiting for cheap shares. Discounted SP + Knowledge = Opportunity $
1 · Reply
Monticello4
Monticello4 Jan. 17 at 11:49 AM
$MDXG just the facts...both are in the shitter...
0 · Reply
RUDYRUDY
RUDYRUDY Jan. 16 at 9:25 PM
3 · Reply
Mobagri
Mobagri Jan. 16 at 8:26 PM
$MDXG new record low again. This company is on a ventilator taking its last breaths. Market cap value based on 2026 forecast should be around 400 million. Nothing in their pipeline to help. Doomsday coming.
1 · Reply
Raiderdave98
Raiderdave98 Jan. 16 at 8:19 PM
$MDXG in the absence of light there is darkness
2 · Reply
Daddys_Home
Daddys_Home Jan. 16 at 8:08 PM
$MDXG FYI, most recent sighting of MiMedx CEO Joe Capper. Holding onto that cash while the stock plunges to another 52 week low. No update to investors, no stock buyback.........ask why?
1 · Reply
RUDYRUDY
RUDYRUDY Jan. 16 at 7:55 PM
1 · Reply
Daddys_Home
Daddys_Home Jan. 16 at 6:23 PM
$MDXG FYI, new 52 week low today @5.47📉 #doomsdayQ1forcastiscoming want go know why? ask me!
1 · Reply
SnapCrackleStop
SnapCrackleStop Jan. 16 at 2:47 PM
$MDXG CELERA & EMERGE
2 · Reply
SnapCrackleStop
SnapCrackleStop Jan. 16 at 2:46 PM
$MDXG Based on updated Medicare Local Coverage Determinations (LCDs) for skin substitutes, effective in 2025 and moving into 2026, many MiMedx products are recognized as covered, while others may not meet the specific, updated criteria for coverage. ® Covered MiMedx Products • EPIFIX® • EPICORD® ®
1 · Reply
QuantitativeTrading_
QuantitativeTrading_ Jan. 16 at 9:16 AM
$DIA isn’t out to replace Chainlink — it’s covering the gaps Chainlink leaves behind: If this helps, tap @QuantitativeTrading_ Transparency via Lumina Faster listing of new assets Lower costs for builders If you’re bullish on RWA and L2 growth, $DIA could be the most undervalued play in the Oracle space. 📌 Educational only — not financial advice. Always DYOR. $MDXG $NCEW
0 · Reply
Daddys_Home
Daddys_Home Jan. 16 at 2:59 AM
$MDXG Goodnight Y'all. I will not stop spreading the upcoming doomsday news on Q1 earnings. I appreciate everyone who reached out and challenged my view. I would love to keep the conversation going. Two questions to ponder as you get ready to hit the sack. #1. How much rev in 2025 came from EpiEffect, Celera, and Emerge? (I believe 100-150m) #2. How will they make that rev up in 2026; now that all of these products are on CMS "do not use list" (Bonus Question): Why were these products used so much and why did CMS put them on the list. Time for this messenger to get some sleep. Tomorrow I will discuss each of these products in detail and why MiMedx has barley mentioned them online (their little secret) #MiMedxBadNewsIsComing #Q1Earnings2026
3 · Reply